HRES-1112-119
Referred to the House Committee on Energy and Commerce.
Sponsored by Gregory Murphy (R-NC)
What it does
This resolution would express House support for the goals of "Deep Vein Thrombosis and Pulmonary Embolism Awareness Month" in March. It is a symbolic measure that recognizes the health risks of these conditions but does not create programs, spending, or regulatory changes.
Who benefits
Patient advocacy organizations and awareness campaigns focused on deep vein thrombosis and pulmonary embolism, who gain symbolic congressional recognition; the public may indirectly benefit from any resulting increase in awareness of preventable clotting conditions.
Who is hurt
No group is meaningfully harmed. The resolution carries no funding, mandates, or regulatory effect on any industry or population.
Supporters argue
Supporters argue that deep vein thrombosis and pulmonary embolism affect up to 900,000 Americans annually and kill an estimated 60,000 to 100,000 people, often without warning, so raising public awareness could help people recognize symptoms and seek timely treatment. They contend that commemorative resolutions like this one have historically helped spotlight underrecognized health conditions and encourage preventive screening.
Opponents argue
Opponents argue that symbolic health-awareness resolutions consume floor and committee time without producing measurable public health outcomes, funding, or enforceable action. They contend that if Congress wants to meaningfully address preventable deaths from these conditions, it should pursue substantive legislation such as research funding or clinical guideline mandates rather than a nonbinding resolution.